Browsing: Positive

BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 (GLOBE NEWSWIRE) — Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation approval under exceptional circumstances for NEZGLYAL® (leriglitazone) as a treatment for male cALD patients, aged 2-12 years with Gadolinium…

SAN JOSE, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today reported positive initial data from the ongoing Phase 1 study of RT-114, an orally administered RaniPill ® Capsule delivering PG-102, a GLP-1/GLP-2 dual agonist being developed by ProGen Co.,…